Found 14 results

Name Type of Offering Accepted Date
BioPharma d'Azur, Inc. See All Filings
D 2014-04-02
Amount To Be Raised $1,020,250
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001144204-14-020145
Exclusions or Exemptions 506b
Accepted Date 2014-04-02
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
First Wave BioPharma, Inc. See All Filings
D 2022-12-01 16:12:59
Amount To Be Raised $2,500,001
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001104659-22-123662
Exclusions or Exemptions 506b
Accepted Date 2022-12-01 16:12:59
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
AzurRx BioPharma, Inc. See All Filings
D 2020-07-31 12:26:01
Amount To Be Raised $22,800,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0000905718-20-000795
Exclusions or Exemptions 506b
Accepted Date 2020-07-31 12:26:01
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
First Wave BioPharma, Inc. See All Filings
D 2022-07-26 17:00:48
Amount To Be Raised $300,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001104659-22-082821
Exclusions or Exemptions 506b
Accepted Date 2022-07-26 17:00:48
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
First Wave BioPharma, Inc. See All Filings
D 2023-06-28 16:05:20
Amount To Be Raised $431,083
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001104659-23-075792
Exclusions or Exemptions 506b
Accepted Date 2023-06-28 16:05:20
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
AzurRx BioPharma, Inc. See All Filings
D 2020-01-17 16:56:07
Amount To Be Raised $8,000,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001415889-20-000125
Exclusions or Exemptions 506b
Accepted Date 2020-01-17 16:56:07
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets No Revenues
Type of Security Debt
AzurRx BioPharma, Inc. See All Filings
D 2019-02-28 18:22:24
Amount To Be Raised $2,000,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001415889-19-000233
Exclusions or Exemptions 506b
Accepted Date 2019-02-28 18:22:24
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets No Revenues
Type of Security Debt
First Wave BioPharma, Inc. See All Filings
D 2023-09-21 16:12:35
Amount To Be Raised $1,470,509
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001104659-23-102819
Exclusions or Exemptions 506b
Accepted Date 2023-09-21 16:12:35
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire
AzurRx BioPharma, Inc. See All Filings
D 2014-11-03
Amount To Be Raised $7,000,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001415889-14-003295
Exclusions or Exemptions 506b
Accepted Date 2014-11-03
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Debt
AzurRx BioPharma, Inc. See All Filings
D 2016-04-11
Amount To Be Raised $12,000,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001415889-16-005478
Exclusions or Exemptions 506b
Accepted Date 2016-04-11
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Debt
AzurRx BioPharma, Inc. See All Filings
D 2017-06-15 13:14:40
Amount To Be Raised $5,000,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001415889-17-001001
Exclusions or Exemptions 506b
Accepted Date 2017-06-15 13:14:40
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
AzurRx BioPharma, Inc. See All Filings
D 2017-04-21 12:38:42
Amount To Be Raised $1,000,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001415889-17-000663
Exclusions or Exemptions 506b
Accepted Date 2017-04-21 12:38:42
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets No Revenues
Type of Security Debt
First Wave BioPharma, Inc. See All Filings
D 2023-03-23 17:00:04
Amount To Be Raised $4,000,001
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001104659-23-036120
Exclusions or Exemptions 506b
Accepted Date 2023-03-23 17:00:04
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
Entero Therapeutics, Inc. See All Filings
D 2025-08-18 10:40:07
Amount To Be Raised $3,025,000
Associated Brokers / Dealers N/A
CIK Number 0001604191
Filed Document 0001104659-25-079619
Exclusions or Exemptions 506b
Accepted Date 2025-08-18 10:40:07
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Option To Acquire